🇺🇸 Non-Early aspirin Therapy in United States

Non-Early aspirin Therapy (Non-Early aspirin Therapy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Non-Early aspirin Therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Non-Early aspirin Therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Non-Early aspirin Therapy in United States?

Second Affiliated Hospital, School of Medicine, Zhejiang University is the originator. The local marketing authorisation holder may differ — check the official source linked above.